Rectal cancer
Cancer marKers to predict complications after CRS-HIPEC surgery for abdominal cancers
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial Hospital MumbaiMumbai, MaharashtraDirections ↗
Registry summary (technical)
Cancer Related Inflammatory and Systemic nutritional marKers as predictors of postoperative complications and survival after cytoreductive surgery and HIPEC for peritoneal cancers (RISK-HIPEC Study) - RISK-HIPEC
Sponsor: Dr Sohan Lal Solanki
CTRI/2025/05/086173 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 1 Jun 2026 · read by us 5 Nov 2026